LMX1A
protein-codingLIM homeobox transcription factor 1 alpha, the group of LIM class homeoboxes
Gene summary
This gene encodes a homeodomain and LIM-domain containing protein. The encoded protein is a transcription factor that acts as a positive regulator of insulin gene transcription. This gene also plays a role in the development of dopamine producing neurons during embryogenesis. Mutations in this gene are associated with an increased risk of developing Parkinson's disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
- LMX1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~154.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011074
Submitter: Ambry Genetics
Inheritance Pattern: SD
Disease ID:MONDO:0011074
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0011074
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0011074
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: ClinGen
LMX1A was first reported in relation to autosomal dominant nonsyndromic deafness in 2018 (Wesdorp et al., PMID: 29754270). In affected probands, the degree of hearing loss ranges from mild to profound, and the age of onset from congenital to middle adulthood. Also, the hearing loss may be symmetrical or asymmetrical. 12 variants (missense, nonsense, frameshift) that have been reported in at least 26 probands in 7 publications (PMIDs: 29754270, 32840933, 35254497, 35711095, 36140227, 36519758, 38056549) are included in this curation. The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse models; PMIDs: 10693804, 23226461; https://www.jax.org/strain/002624). Three homozygous mutant mouse models show deafness, inner ear structural anomalies, shortened tails, white belly spotting, and atypical behavior. In summary, there is definitive evidence supporting the relationship between LMX1A and autosomal dominant nonsyndromic deafness. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date 4/16/25 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0008006
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0019588
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LMX1A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_177398.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 12 | 1 | 14 | ||
| missense | 3 | 2 | 74 | 6 | 85 | |
| nonsense | 1 | 4 | 1 | 6 | ||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 5 | 7 | 76 | 18 | 1 | 107 |
Highest pathogenic variant AF is 0.00001177166
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_796372.1 | 8 | MANE Select | |
| Ensembl | ENSP00000340226.3 | 8 | MANE Select | |
| RefSeq | NP_001167540.1 | 8 | Standard | |
| Ensembl | ENSP00000294816.2 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Dopaminergic Neurogenesis
Biological Process
- regulation of cell growth
- axon guidance
- memory
- locomotory behavior
- dentate gyrus development
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- protein binding
- metal ion binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000342310
- Coding exons
- 8
- Length
- 154849
- Individuals with no LoFs
- 125725
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 6
- Defined
- 125731
- p
- 0.0000239
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.00 | 175 | 216 | 0.808 | 0.0000114 | 2500 |
| Missense (PolyPhen) | 56 | 91.757 | 0.61031 | 1036 | ||
| Synonymous | 0.565 | 82 | 88.8 | 0.924 | 0.00000482 | 725 |
| Loss of Function | 4.06 | 2 | 23.0 | 0.0870 | 0.00000132 | 232 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as a transcriptional activator by binding to an A/T-rich sequence, the FLAT element, in the insulin gene promoter. Required for development of the roof plate and, in turn, for specification of dorsal cell fates in the CNS and developing vertebrae (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.230
Intolerance Scores
- LoFtool
- 0.0623
- RVIS EVS
- -0.74
- RVIS percentile EVS
- 13.94
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.986
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |